Tingting Wang

Tingting Wang

Auto-generated profile, based on publicly available information

Tingting Wang

Resident, Department of 2nd Dental Center, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology, Shanghai, PR China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2015 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
TWTingting Wang
Tingting Wang
LZLi Zhai
Li Zhai
HZHongyan Zhang
Hongyan Zhang
LZLi Zhao
Li Zhao
YGYunliang Guo
Yunliang Guo

4 May 2022 in International Journal of Oncology
Verified
Journal Article
Open access
PDF file
ZZZhaomu Zeng
Zhaomu Zeng
YCYueyue Chen
Yueyue Chen
XGXiuchao Geng
Xiuchao Geng
YZYuhao Zhang
Yuhao Zhang
XWXichao Wen
Xichao Wen
ZSZhiwei Sun
Zhiwei Sun
As the most common primary tumour of the central nervous system, gliomas have a high recurrence rate after surgical resection and are resistant to chemotherapy, particularly high‑grade gliomas dominated by glioblastoma multiforme (GBM). The prognosis of GBM remains poor despite improvements in treatment modalities, posing a serious threat to human health. At present, although drugs such as temozolomide, cisplatin and bevacizumab, are effective in improving the overall survival of patients with GBM, most patients eventually develop drug resistance, leading to poor clinical prognosis. The development of multidrug resistance has therefore become a major obstacle to improving the effectiveness of chemotherapy for GBM. The ability to fully understand the underlying mechanisms of chemotherapy resistance and to develop novel therapeutic targets to overcome resistance is critical to improving the prognosis of patients with GBM. Of note, growing evidence indicates that a large number of abnormally expressed noncoding RNAs (ncRNAs) have a central role in glioma chemoresistance and may target various mechanisms to modulate chemosensitivity. In the present review, the roles and molecular mechanisms of ncRNAs in glioma drug resistance were systematically summarized, the potential of ncRNAs as drug resistance markers and novel therapeutic targets of glioma were discussed and prospects for glioma treatment were outlined. ncRNAs are a research direction for tumor drug resistance mechanisms and targeted therapies, which not only provides novel perspectives for reversing glioma drug resistance but may also promote the development of precision medicine for clinical diagnosis and treatment.

18 December 2017 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
SLShan Li
Shan Li
TWTingting Wang
Tingting Wang
LZLi Zhai
Li Zhai
KGKeli Ge
Keli Ge
ZJZhao Jun
Zhao Jun
YGYunliang Guo
Yunliang Guo

15 February 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CTChen Tao
Chen Tao
ZGZai-Pei Guo
Zai-Pei Guo
LLLi Li
Li Li
MLMengmeng Li
Mengmeng Li
TWTing-Ting Wang
Ting-Ting Wang
JLJing-Yi Li
Jing-Yi Li
Our previous work indicated that TWEAK is associated with various types of cutaneous vasculitis (CV). Herein, we investigate the effects of TWEAK on vascular injury and adhesion molecule expression in CV mice. We showed that TWEAK priming in mice induced a local CV. Furthermore, TWEAK priming also increased the extravasation of FITC-BSA, myeloperoxidase activity and the expression of E-selectin and ICAM-1. Conversely, TWEAK blockade ameliorated the LPS-induced vascular damage, leukocyte infiltrates and adhesion molecules expression in LPS-induced CV. In addition, TWEAK treatment of HDMECs up-regulated E-selectin and ICAM-1 expression at both mRNA and protein levels. TWEAK also enhanced the adhesion of PMNs to HDMECs. Finally, western blot data revealed that TWEAK can induce phosphorylation of p38, JNK and ERK in HDMECs. These data suggest that TWEAK acted as an inducer of E-selectin and ICAM-1 expression in CV mice and HDMECs, may contribute to the development of CV.

20 October 2016 in Chinese Medical Journal
Verified
Journal Article
Open access
PDF file
JLJing-Yi Li
Jing-Yi Li
LZLiLi Zheng
LiLi Zheng
TWTing-Ting Wang
Ting-Ting Wang
MHMin Hu
Min Hu
Background: Melanoma is a type of cancer that develops from the pigment-containing cells. Until now, its pathological mechanisms remain largely unknown. The aim of this study was to identify metastasis-related microRNA (miRNAs) and gain an understanding of the biological functions in the metastasis of melanoma. Methods: We searched the PubMed and Gene Expression Omnibus database to collect miRNA expression profiling datasets about melanoma, with key words of "melanoma", "miRNA", "microarray", and "gene expression profiling". Only the original experimental works published before June 2016 for analyzing the metastasis of melanoma were retained, other nonhuman studies, reviews, and meta-analyses were removed. We performed a meta-analysis to explore the differentially expressed miRNA between metastatic and nonmetastatic samples. Moreover, we predicted target genes of the miRNAs to study their biological roles for these miRNAs. Results: We identified a total of 63 significantly differentially expressed miRNAs by meta-analysis of the melanoma expression profiling data. The regulatory network constructed by using these miRNAs and the predicted targets identified several key genes involved in the metastasis of melanoma. Functional annotation of these genes indicated that they are mainly enriched in some biological pathways such as mitogen-activated protein kinase signaling pathway, cell junction, and focal adhesion. Conclusions: By collecting the miRNA expression datasets from different platforms, multiple biological markers were identified for the metastasis of melanoma. This study provided novel insights into the molecular mechanisms underlying this disease, thereby aiding the diagnosis and treatment of the disease.

1 June 2023 in The Journal of Prosthetic Dentistry
Verified
Journal Article
Closed access
TWTingting Wang
Tingting Wang
LYLijuan Ye
Lijuan Ye
YSYuanyuan Sun
Yuanyuan Sun
Yiqun WuYiqun Wu
Yiqun Wu